尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Richard Lowenthal. Officer active across 1 company, notably ARS Pharmaceuticals, Inc.. Aggregated, 6 filings have been published. History available since 18 August 2026. The latest transaction was filed on 11 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
RICHARD LOWENTHAL is a declarant linked to ARS Pharmaceuticals, Inc., where he is Officer, Director, 10% Stockholder. He has 5 filings in total, and in the sampled recent filings from 2026-08-18 to 2026-09-04, they are all sales, totaling EUR 1139778.